Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Atreo
AddedFeb 15, 2024
UpdatedJun 18, 2026
Atreo

Atreo

Atreo.io revolutionizes client experience with innovative RTSM solutions, supporting 1000+ clinical trials.

HQ
San Francisco, CA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Atreo was founded with the mission to revolutionize the client experience in the realm of Randomization and Trial Supply Management (RTSM). The company focuses on providing innovative, customizable RTSM solutions that can be rapidly deployed within 1-2 weeks. Atreo's services cater to a diverse range of clients, from emerging biotech firms to top-tier pharmaceutical companies and Contract Research Organizations (CROs). Their modern and collaborative System Design Experience allows clients to explore and refine fully functional RTSM systems tailored to their specific protocols from day one.

Notable figures affiliated with Atreo include a team with extensive experience across all aspects of RTSM, Clinical Supplies, and Clinical Trials project delivery. The company has supported over 1000 clinical trials, demonstrating significant expertise and impact in the industry. Key achievements include offering 10x testing coverage compared to legacy RTSM providers and unmatched system configurability and agility post-launch. Atreo's innovative approach has set a new standard for client experience in clinical trial management, making a substantial impact on the efficiency and effectiveness of clinical trials globally.

Atreo - Similar Companies

4G Clinical logo

4G Clinical

Endpoint Clinical logo

Endpoint Clinical

Korio logo

Korio

korioclinical.com

On-Time Trials logo

On-Time Trials

ontimetrials.com

Clinical Research IO logo

Clinical Research IO

Strategikon Pharma logo

Strategikon Pharma

Clinical.Ly logo

Clinical.Ly

clinical.ly

Citruslabs logo

Citruslabs

citruslabs.com

atript logo

atript

Miracle logo

Miracle

miracleml.com

Faro Health logo

Faro Health

farohealth.com

TrialSpark logo

TrialSpark

trialspark.com

RxE2 logo

RxE2

rxe2.com

Atropos Health logo

Atropos Health

atroposhealth.com

Jeeva logo

Jeeva

jeevatrials.com

Atreo - Quick Facts

Who are Atreo's competitors?

Companies similar to Atreo include 4G Clinical, Endpoint Clinical, Korio and On-Time Trials.

When was Atreo founded?

Atreo was founded in 2021.

Where is Atreo's headquarters located?

Atreo's headquarters is located in San Francisco, CA, US.

When was Atreo's last funding round?

Atreo's most recent funding round was for $4M (USD) in June 2022.

How much has Atreo raised to-date?

As of Jun 6, 2022, Atreo has raised a total of $5.8M (USD).

How many employees does Atreo have?

Atreo has 23 employees as of Feb 4, 2024.

Atreo - Classification

Ownership
  • Private
Technology
  • Software
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • RTSM Solutions
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 20 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 513210Software Publishers
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 7300Business Services
  • 8000Health Services
  • 2830Drugs
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified